Cargando…
Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia
BACKGROUND: Acute myelogenous leukemia (AML) is a common pediatric malignancy in children younger than 15 years old. Although the overall survival (OS) has been improved in recent years, the mechanisms of AML remain largely unknown. Hence, the purpose of this study is to explore the differentially m...
Autores principales: | Zheng, Jiafeng, Zhang, Tongqiang, Guo, Wei, Zhou, Caili, Cui, Xiaojian, Gao, Long, Cai, Chunquan, Xu, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758482/ https://www.ncbi.nlm.nih.gov/pubmed/33363022 http://dx.doi.org/10.3389/fonc.2020.591937 |
Ejemplares similares
-
Development and validation of a nomogram to predict plastic bronchitis in children with refractory Mycoplasma pneumoniae pneumonia
por: Zhao, Lihua, et al.
Publicado: (2022) -
Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017) -
Systematic Construction and Validation of a Metabolic Risk Model for Prognostic Prediction in Acute Myelogenous Leukemia
por: Wang, Yun, et al.
Publicado: (2020) -
Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022) -
Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation
por: Liesveld, Jane
Publicado: (2012)